Cornerstone Research has decades of substantive experience in securities class action and securities direct action matters. Our experience encompasses matters in which the economic evidence presented by our experts has contributed to notable favorable outcomes for our clients across legal jurisdictions.
Cornerstone Research’s recent securities litigation experience includes matters involving securities such as common stock, American Depositary Shares, fixed income securities, and options. Claims addressed include Rule 10b-5, Section 11, and Section 12(a), with allegations relating to accounting and financial reporting, business prospects, company operations, and government investigations and approvals, among others. The matters span many industries including life sciences; healthcare; financial institutions; telecom, media, and entertainment; energy; and manufacturing.
Select matters in which economic evidence contributed to favorable outcomes at the class certification stage:
Rule 10b-5 claims involving common stock against a mortgage company regarding its outlook during the COVID-19 pandemic.
Rule 10b-5 claims against a company that mines and processes gold regarding growth prospects.
Rule 10b-5 claims against a financial institution regarding its business principles and management of conflicts of interest.
Rule 10b-5 claims involving common stock against an inpatient substance abuse treatment company regarding its marketing behaviors.
Rule 10b-5 claims against a biopharmaceutical company regarding its representation of an upcoming drug and its trial results.
Section 12(a) claims involving common stock against an international restaurant franchising company regarding its CEO acting as both CEO and attorney-in-fact for board members.
Rule 10b-5 claims against a technology company that sells fiber optic subsystems regarding its inventory build-up.
Rule 10b-5 claims against an international oil company regarding process safety improvements.
Select matters in which economic evidence contributed to favorable outcomes at the Motion for Summary Judgment stage:
Section 11 and Section 15 claims against a software company regarding omissions in its offering materials.
Rule 10b-5 claims against a company that mines and processes gold regarding growth prospects.
Section 11 and Section 12(a) claims against a software company providing data warehousing and management tools regarding its cloud expertise.
Section 11 and Section 12(a) claims involving American Depositary Shares (ADS) of a large financial institution regarding exposure to credit risk.
Rule 10b-5 claims against an international oil company regarding an oil spill.
Rule 10b-5 claims against a global marketing and advertising holding company regarding its accounting of a transaction.
Cornerstone Research has been involved in notable securities class action trials:
Rule 10b-5 claims against a biopharmaceutical company regarding the safety and effectiveness of one of its drugs.
Rule 10b-5 claims against a fiber optic company regarding its representation of accelerating demand and the success of acquisitions.